OTC · BICX
BioCorRx Inc.
$0.25+$0.04 (+18.48%)
BioCorRx Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.47% below the high.
Loading market information…
OTC · PMEDF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Qscreen Ai Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qscreen Ai Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
QScreen AI, Inc. is a life sciences technology firm that specializes in pioneering artificial intelligence (AI) solutions. These innovative technologies are designed to enhance general workplace health and safety, and to serve the wider healthcare industry. The company also furnishes specialized tools for medical practitioners. Established on September 3, 1987, its principal operations are based in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.25+$0.04 (+18.48%)
BioCorRx Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.47% below the high.
$0.00$0.00 (0.0%)
Bioelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 78.57% below the high.
CA$0.05CA$0.00 (0.0%)
PharmaCielo Ltd.’s quoted price sits in the lower half of its reported 52-week range, 69.7% below the high.
CA$0.04CA$0.00 (0.0%)
Kane Biotech Inc.’s quoted price sits in the upper half of its reported 52-week range, 30.0% below the high.
$0.06+$0.02 (+50.0%)
ADM Tronics Unlimited, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
REMSleep Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.22% below the high.
$0.03$0.00 (0.0%)
Fuse Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.05$0.00 (0.0%)
Vycor Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.0% below the high.
